Background and aims: Optimal management of Patent Ductus Arteriosus(PDA) in ELBW infants is controversial and trials of therapeutic intervention have not shown benefit. In our unit we practice early extubation to CPAP, permissive hypercapnia and only consider PDA treatment when infants remain ventilator-dependent. The aim of this study is to audit PDA treatment in our unit and following discharge, and to compare short-term outcomes to published benchmarks.
Methods:
Retrospective study of all ELBW infants who were inborn or admitted to our unit within 72 hours of birth from [2007] [2008] [2009] Conclusion: While these data have not been risk-stratified, treatment of PDA in ELBW babies in our unit appears to be considerable lower than in VON, but this is not associated with significant differences in outcome. A trend to increased rate of NEC requires further study.
